NADH and NADPH pharmaceuticals for treating chronic fatigue synd

Details NADH and NADPH pharmaceuticals for treating chronic fatigue synd NADH and NADPH pharmaceuticals for treating chronic fatigue synd

1996-04-22

1998-01-27

Wilson, James O.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

514 45, 514 46, 514 47, 536 2613, 536 2623, 536 2624, A61K 3170

Patent

active

057122598

ABSTRACT:
A method for treating Chronic Fatigue Syndrome or alleviating symptoms thereof wherein the reduced form of nicotinamide adenine dinucleotide (NADH) or the reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) or physiologically compatible salts or derivatives of NADH and/or NADPH are administered to a person suffering from the syndrome or its symptoms. Patients so treated exhibit greatly improved physical strength and performance over time, and their symptoms including fatigue, muscle pain and weakness, and headaches are greatly alleviated.

REFERENCES:
patent: 4970200 (1990-11-01), Birkmayer et al.
patent: 5019561 (1991-05-01), Birkmayer
patent: 5189022 (1993-02-01), Bridge et al.
patent: 5267570 (1993-12-01), Preston
patent: 5312817 (1994-05-01), Snorrason
patent: 5332727 (1994-07-01), Birkmayer
patent: 5424300 (1995-06-01), Uchida
patent: 5444053 (1995-08-01), Birkmayer
patent: 5545670 (1996-08-01), Bissbort et al.

Affiliated with

Also associated with

Rating

NADH and NADPH pharmaceuticals for treating chronic fatigue synd does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with NADH and NADPH pharmaceuticals for treating chronic fatigue synd, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NADH and NADPH pharmaceuticals for treating chronic fatigue synd will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-342384